Skip to main content
Archives of Medical Sciences. Atherosclerotic Diseases logoLink to Archives of Medical Sciences. Atherosclerotic Diseases
. 2024 Mar 30;9:e72–e81. doi: 10.5114/amsad/184245

Cinnamon: a nutraceutical supplement for the cardiovascular system

Taherah Mohammadabadi 1,, Rajesh Jain 2
PMCID: PMC11155465  PMID: 38846056

Abstract

Common therapies for cardiovascular diseases (CVDs) are associated with wide side effects. Thus, herbal medicines have been regarded due to fewer side effects, availability, cultural beliefs, and being cheap. For thousand years, herbal medicine has been used for bacterial infections, colds, coughs, and CVDs. Cinnamon bark contains phenolic compounds such as cinnamaldehyde and cinnamic acid with protective properties which can reduce the risk of cardiovascular diseases, cardiac ischemia and hypertrophy, and myocardial infarction. Furthermore, cinnamon has antioxidant and anti-inflammatory properties and exhibits beneficial effects on the complications of diabetes, obesity, hypercholesterolemia, and hypertension which cause CVDs. Although the protective effects of cinnamon on the heart have been reported in many studies, it needs more clinical studies to prove the pharmaceutical and therapeutic efficacy of cinnamon on risk factors of CVDs.

Keywords: atherosclerosis, cinnamon, cardiovascular disease, nutraceutical

Introduction

About 1/3 to 1/5 of cardiovascular disease (CVD) cases are associated with myocardial infarction and heart failure [1]. Some risk factors for CVDs are smoking, stress, and diseases such as diabetes, atherosclerosis, and hypertension [2]. The application of common therapies for CVDs is associated with side effects, that is why the use of herbal medicines is considered due to less side effects, and being cheap [3]. Herbal medicines have antioxidant, immune regulatory, and anti-inflammatory properties against CVDs [4, 5].

The main commercial species of cinnamon are Cinnamomum verum, Cinnamomum burmannii, Cinnamomum cassia, and Cinnamomum loureiroi [6, 7], and the most common species are Cinnamomum cassia (Saigon Cinnamon) and Cinnamomum verum (Ceylon Cinnamon) [8]. Saigon Cinnamon is the most well-known and is found in Vietnam, China, and Sunda Islands. Ceylon Cinnamon as one of the best types of cinnamon is an evergreen tree with 5–7 m and is native to India, Bangladesh, and Myanmar [8]. Leaves and bark of cinnamon trees have been used as herbal medicine, flavoring, or spice and the most consumed part of the plant is the bark [7]. Bioactive compounds of cinnamon are against inflammation, oxidative stress, diabetes, obesity, hypertension, and high blood lipid levels [9, 10]. In traditional medicine, cinnamon has been used for arthritis, infections, as an analgesic agent, and for wound healing [9]. It’s reported that it may impact the risk of cardiovascular diseases, diabetes, and cancer. The effect of cinnamon on lipid levels or plasma glucose indicated promising results [11].

This review is to highlight the scientific studies revealing the cardiovascular beneficial effects of cinnamon on CVDs.

The bioactive compounds

The main components of cinnamon are cinnamaldehyde and trans-cinnamaldehyde which are linked to fragrance and its biological properties [7] Catechins and procyanidins; proanthocyanidins or condensed tannins are found in the cinnamon bark which belongs to the flavan-3-ols as important flavonoids [12]. As stated by Vallverdu-Queralt et al., the most abundant bioactive compounds found in cinnamon are catechin, protocatechuic acid, quercetin, epicatechin, p-coumaric acid, p-hydroxybenzoic acid, syringic acid, rosmarinic acid, caffeic acid, ferulic acid, and chlorogenic acid [13] (Figure 1).

Figure 1.

Figure 1

Major bioactive compounds in the cinnamon bark

It is reported that cinnamon is rich in cinnamaldehyde, cinnamic acid, cinnamate, and eugenol as the main components [9, 14]. It is reported that amidone, mucilage, tannin, calcium oxalate, sugar, essential oil, and resin also were found in cinnamon [15].

Cinnamic, cinnamyl acetate, cinnamaldehyde, procyanidins, polysaccharide, and catechins are major components in the cinnamon bark. A higher concentration of cinnamaldehyde has shown cardiovascular protective properties while cinnamic acid, coumarin, cinnamyl alcohol, and eugenol are used for flavoring and perfumes [16]. The common extraction methods for cinnamaldehyde, cinnamic acid, cinnamate, and eugenol as the main components of cinnamon are steam distillation, hydro-distillation, and Soxhlet extraction [17, 18]. Hydro-distillation is more used because of its low cost, easiness, and lack of solvent residue. But generally, its yields are low (1–2%) [19], thus other extraction methods such as supercritical CO2 extraction, ultrasonic, microwave-assisted extraction, and low-temperature extraction have been performed to increase extraction yields [20, 21] (Figure 2).

Figure 2.

Figure 2

Extraction methods for bioactive components of cinnamon (adapted from [25])

Health benefits of cinnamon

According to traditional medicine in Iran and India, the temperament of Ceylon and Saigon cinnamons is warm and dry [22]. Cinnamon has been used to cleanse the breast, treat coughing and shortness of breath, and thick phlegm, and is used for obsessive-compulsive disorder, panic, insanity, stomach ache, relieving fever, and reduction of joint and back pain. In India and China, it is proven that Ceylon cinnamon’s bark is a stimulant for the digestive, respiratory, and kidney diseases and accelerates blood flow. In contrast, Saigon cinnamon is used as a spice due to its flavor. In traditional Far-Eastern medicine, cinnamon has been advised as a stomach booster and sedative, applied for postpartum pain, and increases the body’s secretions [22] (Figure 3).

Figure 3.

Figure 3

Cinnamon plant, bark, and leaves

Cinnamon is an anti-clotting agent and prevents atherosclerosis. In addition, it decreases blood cholesterol and insulin resistance, stabilizes blood sugar, and maintains LDL. Cinnamaldehyde dilates blood vessels and helps relieve the tension due to blood pressure. Ingesting 6 g of cinnamon daily lowers triglyceride and total cholesterol in type 2 diabetes. Cinnamon can reduce inflammation that is triggered by obesity [22].

Cinnamomum zeylanicum has a blood pressure lowering effect in rat models [23] as well as suggesting in type 2 diabetic and pre-diabetic humans a NO-dependent mechanism for the antihypertensive effects of C. zeylanicum [24]. Nonetheless, outcomes of a placebo-controlled clinical trial showed that cinnamon does not affect BP in type 2 diabetic cases [14]. Cinnamon affects regulations and mimics, which may have a moderate effect on lowering fasting blood sugar in diabetes. Cinnamon can also keep blood sugar steady throughout the day [25]. Cinnamon reduces the production of the inflammatory molecule of thromboxane A2 in patients suffering from heart diseases. Also, cinnamon’s anti-inflammatory properties prevent the release of arachidonic acid (inflammatory fatty acid) that promotes plaque formation in the arteries. Cinnamon is a rich source of flavonoids and antioxidants which are anti-inflammatory and decrease heart diseases [22]. Cinnamon and cinnamaldehyde have prebiotic effects as well that may restore the balance of gut bacteria and improve digestive functions [22].

Beside many other factors, subspecies, extraction mode and galenic properties influence the required doses [26]. Cinnamon is generally safe when used in small amounts. Usually, it is used about 1–6 g depending on the weight. Since Saigon cinnamon contains higher coumarin (5.8 to 12.1 mg) than Ceylon cinnamon, so one should reduce its intake [26].

The effect of cinnamon on the cardiovascular system

As explained in the previous parts of the current review, the most important compounds of cinnamon are cinnamaldehyde, cinnamic acid, eugenol, and coumarin [27], out of which cinnamaldehyde is the main bioactive compound (60–75%) [28]. This compound has protective effects on cardiovascular conditions like cardiac ischemia and hypertrophy, and myocardial infarction [29, 30]. Using 100 mg cinnamon/kg body weight for 2 weeks had significant antioxidant ability in reducing the complications related to oxidative stress and increased total antioxidant power by reducing lipid peroxidation. Cinnamon supplementation improves the performance of the heart and increases coronary flow by enhancement of cardiac performance [31].

The consumption of 500 mg cinnamon/kg body weight in type 2 diabetic patients for 2 months reduced blood sugar and lipid levels. Using cinnamon along with turmeric, and chili pepper in CVD patients for 11 years showed that cinnamon did not affect blood lipids and CVDs. Daily consumption of 1 g cinnamon powder/kg body weight for 16 months in male diabetic patients reduced diabetes complications [22].

The effect of cinnamon on atherosclerosis

There is an accumulation of cholesterol and inflammatory cells in the artery wall in atherosclerosis [32]. Atherosclerosis causes cardiovascular diseases such as myocardial infarction, stroke, and ischemic heart failure [33]. Inflammation and oxidative stress play a key role in cardiovascular diseases. It is confirmed that the therapeutic properties of cinnamaldehyde improve oxidative stress-mediated cardiovascular diseases, in atherosclerosis patients [34]. It is declared that cinnamaldehyde protects smooth muscle cells against LDL oxidation-induced proliferation [34]. The protective and anti-inflammatory effects of cinnamaldehyde on the oxidative stress induced by H2O2 in the endothelial cells of the human umbilical vein in Sprague-Dawley rats in vivo were proved [35]. It’s concluded that cinnamaldehyde could inhibit atherosclerotic damage in the aortas due to antioxidant effects in ovariectomized female mice [30]. The effects of cinnamaldehyde on the vascular damage induced by a high-cholesterol diet in rabbits were reported [36]. Also, cinnamaldehyde improved atherosclerosis in hypercholesterolemic rabbits by decreasing cholesterol and antioxidant and anti-inflammatory properties. The researchers declared that cinnamon showed preventive effects on the formation of atherosclerotic plaques, which inhibits the increase of fibrosis, neutrophils, and hypertrophy and reduce NO concentration [23, 37]. Cinnamon leads to the reduction of negative inotropic and chronotropic effects in the heart, the relaxation of the VSM wall, and the improvement of systolic and diastolic failures by reducing the calcium channel activity [38].

The effect of cinnamon on anti-platelet aggregations

Prolonged use of anti-platelet aggregation drugs has various side effects, therefore natural sources have been considered. Some compounds of cinnamon C. cassia such as eugenol, amygdala, cinnamic alcohol, 2-hydroxy cinnamaldehyde, 2-methoxycinnamaldehyde, and conifer aldehyde displayed antiaggregatory activity [25]. Cinnamaldehyde inhibited platelet aggregation induced by collagen and thrombin in vitro and platelet aggregation in vivo [39]. The administration of cinnamaldehyde to mice inhibited platelet-related thrombosis. Eugenol in cinnamon reduced platelet aggregation by inhibiting thromboxane A2. The administration of cinnamaldehyde to aortic banding mice mitigated the development of pathological cardiac hypertrophy and heart failure [40]. Cinnamon extract had anticoagulant and anti-aggregation properties for the platelets [8]. Administration of cinnamon to hypercholesterolemic rats increased HDL and decreased triglyceride and LDL cholesterol levels [8]. The cinnamon may prevent the release of arachidonic acid from phospholipids of platelet membrane and reduces the production of thromboxane A2. Also, it decreases triglyceride, LDL, and total cholesterol and increases HDL. Because LDL and Ox-LDL have a high affinity for CD36 that cause platelet activation, thus a reduction in LDL decreases platelet activation [8] (Figure 4).

Figure 4.

Figure 4

The effect of cinnamon on platelets (adapted from [8])

The effect of cinnamon on blood lipids

Using one cinnamon extract capsule (250 mg/kg body weight) in type 2 diabetes patients for 2 months reduced total cholesterol (TC), HDL, and LDL [41]. Also, in type 2 diabetes patients, using cinnamon (3 g) reduced HDL and LDL [14]. The practice of 500 mg cinnamon extract/kg body weight for 1 year had no advantageous effect on electrocardiogram (ECG) indicators in at-risk diabetic persons [42]. Hyperlipidemia is linked with a high incidence of myocardial infarctions and cardiovascular diseases. The cinnamaldehyde and polyphenols present in cinnamon have antihyperlipidemic effects [34]. A study on the blood lipids of patients with CVDs and cancer during 11 years proved that cinnamon did not affect CVDs [43]. The use of 300 and 600 mg cinnamon extract/kg body weight alone and with metformin (250 mg/kg body weight) for 30 days in type 2 diabetes rats increased HDL but reduced TC and LDL levels [44]. An alternative study exhibited that 300 mg cinnamon extract/kg body weight for 18 days enhanced HDL and LDL in type 2 diabetes antenatal rats [45]. Daily use of 300 mg cinnamon alcoholic extract/kg along with 20 mg captopril/kg for 4 weeks reduced TC and LDL, increased HDL, and improved atherogenic index in acute hypertension rats [23]. Supplementation of 100 mg cinnamon extract/kg body weight in metabolic syndrome rats for 12 weeks reduced TC and LDL levels and increased HDL [46]. The use of 200 mg cinnamon alcoholic extract/kg/day for 8 weeks in rats improved cardiac hemodynamics, decreased serum malondialdehyde, improved hyperlipidemia, and decreased TC, LDL, HDL, and LDL/HDL ratio [31]. Consumption of 500 and 300 mg cinnamon alcoholic extract/kg body weight improved HDL and reduced TC and LDL levels in type 2 diabetes and hyperlipidemia rats [47, 48]. It is proved that the cinnamon extract in different doses in type 2 diabetes rats reduced alanine aminotransferase, aspartate aminotransferase, and LDH levels [44]. The different impacts of the cinnamon extract on serum parameters are due to differences in the extraction method, the type of solvent, or the dose of cinnamon [49].

According to many studies, cinnamon regulates blood lipids, reduces LDL and TC levels, and improves blood lipids in obese diabetes cases fed with high-fat diets [50]. Although, some studies have declared the protective effects of cinnamon on the heart; however, in some other studies, cinnamon had no beneficial effect on the blood lipid [42]. In many studies, cinnamon reduced HDL levels [41], but further studies need to prove the effect of cinnamon on HDL [45, 51]. Figure 5 shows the effect of cinnamon on serum levels of sugar, lipids, blood pressure, and cardiovascular tissue changes such as apoptosis, inflammation, and fibrosis.

Figure 5.

Figure 5

The effect of cinnamon on the cardiovascular system (adapted from [22])

Using a 100 mg cinnamon capsule significantly decreased blood TG and total cholesterol but did not change LDL-c and HDL-c and had a small effect on impaired glucose tolerance in diabetic patients [52]. Supplementation of 1.5 g cinnamon/day for 60 days in type 2 diabetes patients increased HDL and reduced triglyceride and cholesterol levels [53, 54] (Figure 6).

Figure 6.

Figure 6

The effect of the cinnamon extract on blood lipids and the cardiovascular system (adapted from [22])

The utmost substantial risk indicators for cardiovascular changes are the amplified serum cholesterol, TG, LDL, and reduced HDL all of which are linked to oxidative stress. Cinnamon may increase the efficacy of HDL-mediated reverse cholesterol transport, consequently decreasing the cardiovascular disease risk [31].

The effect of cinnamon on blood pressure

Administration of 1–10 mg cinnamaldehyde/kg decreased blood pressure in anesthetized dogs and guinea pigs, due to peripheral vasodilating effects. The hypotensive effects were proved by vasorelaxant action and negative inotropic and chronotropic properties on the heart in anesthetized rats [25]. The vasodilatory action of cinnamaldehyde relaxed the rat aortic rings precontracted with phenylephrine. It’s showed that cinnamaldehyde elevates methylglyoxal-induced vascular damage in the rat thoracic aorta [55]. The aromatic carboxylic acid and cinnamic acid of cinnamon also exhibit vasorelaxant effects in rat thoracic aortas [56] which prove protective effects against myocardial ischemia in Sprague-Dawley rats treated with isoproterenol [57]. According to meta-analyses, the effectiveness of 2 g cinnamon extracts on SBP and DBP for more than 8 weeks was reported [58]. The same effect has been concluded in DM2 patients [59]. The effects on SBP and DBP in patients not older than 50 years are displayed clearly in low doses and longer periods (> 12 weeks) [26]. Another study declared that 1 g of cinnamon per day for 3 months lowered blood pressure in diabetic patients. High blood pressure causes 2/3 of strokes, and 50% of coronary heart disease cases, and is linked to premature coronary artery disease. Using 1500 mg cinnamon capsules for 90 days significantly decreased mean ambulatory SBP and LDL-c, did not change FBS, and increased HDL-c [60]. Cinnamon powder reduced systolic and diastolic blood pressure [61]. In a study on 59 type 2 diabetes patients, a daily intake of 1200 mg cinnamon for 12 weeks reduced systolic blood pressure by an average of 3.4 mm Hg [24].

Cinnamon and diabetes

Currently, diabetes is regarded as the most common metabolic disorder in society, and the prevention of cardiovascular issues in diabetic patients is important. The protective effects of cinnamaldehyde against hypertension in streptozotocin-diabetic and fructose-fed insulin-resistant rats were reported. Furthermore, cinnamaldehyde reduced fibrosis and cardiac inflammation in fructose-fed rats which displayed metabolic syndrome [57]. The antihyperglycemic and antihyperlipidemic function of cinnamaldehyde in insulin-resistant mice was reported after oral administration of cinnamaldehyde. The polyphenols of cinnamon improved regulating blood glucose in humans [62]. The phenolic compounds, catechin, epicatechin, and procyanidin B2 as flavonoids in cinnamon can reduce blood sugar by reducing glycogen synthesis, glycogenolysis, and glucose absorption in the intestine [25]. Furthermore, polyphenols such as rutin, catechin, quercetin, kaempferol, and isorhamnetin in cinnamon can diminish insulin activity and improve glycemic control [7]. The consumption of 500 mg cinnamon/kg body weight in type 2 diabetes patients for 2 months reduced blood sugar and lipid levels [63]. Also, using cinnamon extract capsules (250 mg/kg body weight) in type 2 diabetes patients for 2 months reduced total cholesterol, HDL, and LDL. The consumption of cardamom (3 g), cinnamon (3 g), ginger (3 g), and saffron (1 g) for 8 weeks reduced HDL and LDL in type 2 diabetic patients. Regarding the research, using 500 mg cinnamon extract/kg body weight for 1 year in pre-diabetic patients had no beneficial effect in improving electrocardiogram indicators [23]. It is proved that cinnamon significantly reduced FBG and HOMA-IR, in T2DM and pre-diabetes patients compared to placebo [64].

Cinnamon and obesity

Obesity is strongly linked with cardiovascular diseases. The phytochemicals may be good candidates for anti-obesity drugs due to fewer side effects [25]. The anti-obesity effects of cinnamaldehyde were studied for 8 weeks on mice fed a high-fat diet [28]. Cinnamaldehyde and cinnamic acid have anti-obesity and cardioprotective properties. Also, cinnamaldehyde decreased body weight, fat mass, serum lipid, free fatty acid, and leptin, improved insulin sensitivity, prevented adipose tissue hypertrophy, and induced browning of white adipose tissue in comparison with the controls [65]. It decreased hyperlipidemia and body weight of obese rats on the high-fat diet and protected animals against hypertension and vasoconstriction problems. Supplementations with 2 to 3 g of cinnamon per day significantly impacted the bodyweight, obesity which is linked with cardiovascular disorders. It delayed gastric emptying, gastrointestinal motility, and release of serotonin from enterochromaffin cells. That way it reduces visceral fat deposits as it boosts interscapular brown adipose tissue and thermogenic protein. It also increases glucose transport, insulin β receptors, and zinc finger protein 36 in the adipocytes, and decreases leptin amount [66]. Daily use of 3 g of cinnamon for 8 weeks significantly reduced body fat mass in type 2 diabetes patients [67].

Conclusions

Cinnamaldehyde and cinnamic acid are the main compounds of the cinnamon with protective effects on cardiovascular diseases. Previous studies have reported the beneficial effects of cinnamon on lipid profiles, fasting glucose, blood pressure, cardiovascular disease, diabetes, and consequently mortality. Cinnamon is effective in preventing and treating CVDs by lowering blood lipids and blood pressure and improving the oxidants: antioxidants balance. Therefore, cinnamon has protective effects on the cardiovascular system by reducing oxidative stress and increasing HDL, reducing ischemic damage such as apoptosis in the heart tissue, reducing blood pressure, and having anti-arrhythmic effects (Table I).

Table I.

Overview on the cardiovascular protective properties of cinnamon

Cinnamon Dose used Case Results Reference
Cinnamomum burmannii
60 g/1 l water, heated at 100°C for 30 min
100 ml/day, oral single dose 30 non-diabetic cases (20–53 years) Slightly decreased postprandial blood glucose after 2 h Bernardo et al., 2015 [68]
Cinnamomum burmannii
Extract Herbilogy®
2, 4, and 8 mg/kg B.W, orally for 28 days 30 male, Swiss Webster mice on a high-fat diet Decreased total cholesterol Pulungan and Pane, 2020 [69]
Cinnamomum burmannii
Fine powder
2 g per day, 8 weeks 36 women aged more than 18 years, rheumatoid arthritis pre- and postmenopausal Significant decrease in serum TNF-α, CRP, diastolic blood pressure and swollen joint count, and blood pressure Shishehbor et al., 2018 [70]
Cinnamomum cassia
Bark
1.5 g for 60 days 99 type 2 diabetic patients Reduced HbA1c, glucose, triglyceride, TG/HDL-C ratio, BP, and increased HDL and eGFR Sengsuk et al., 2016 [53]
Cinnamomum cassia
Spray-dried aqueous extract
250 mg twice a day, 2 months 137 Chinese, mean age 61 years, fasting serum glucose: > 6.1 mmol/l Reduced fasting insulin, glucose, total cholesterol, and LDL, improved insulin sensitivity Anderson et al., 2016 [41]
Cinnamomum verum
Bark powder
3 g/day, 8 weeks 99 women with dyslipidemia Reduced total cholesterol, triglyceride, and HDL, BW, BMI Pishdad et al., 2018 [71]
Cinnamomum zeylanicum 85, 250, and 500 mg aqueous for 3 months 28 healthy subjects Reduced systolic and diastolic blood pressure and cholesterol. Renal and liver function, fasting blood glucose, HDL-c, VDL-d, and triglycerides were in the normal range, no changes in the anthropometric parameters Ranasinghe et al., 2017 [72]
Cinnamomum zeylanicum
Bark powder
Three capsules of 500 mg/daily for 8 weeks 84 polycystic ovary syndrome women Increased total antioxidant capacity and Malondialdehyde decreased. Improved total cholesterol, HDL, and LDL Borzoei et al., 2018 [73]
Iranian cinnamon powder 3 g/day8 weeks 39 type 2 diabetes patients, body mass index 27.7 No significant effect in reduction of NF-κB, SIRT1, hs-CRP, IL-6, and TNF-α Davari et al., 2020 [74]
Cinnamic acid 30 mg/kg/day for 7 weeks Rats fed high-fat diet Anti-obesity and cardioprotective Mnafgui et al. (2015) [65]
Cinnamaldehyde 50 mg/kg for 7 weeks Cardiac hypertrophy-induced mice by aortic banding Improve cardiac hypertrophy and fibrosis Yang et al. (2015) [40]
Cinnamaldehyde 10–100 µM Isolated rat aortae subjected to vascular damage by methylglyoxal Vasculoprotective effects Tarkhan et al. (2018) [55]
Cinnamon powder 1000 mg/kg, 16 months Type 2 diabetes cases Preventing cardiac ischemia Crawford et al. (2018) [70]
Cinnamon extract 500 mg/kg, 2 months Type 2 diabetes cases Decreased TC, HDL, LDL Anderson et al. (2016) [41]

Funding Statement

Funding No external funding.

Ethics approval

Not applicable.

Conflict of interest

The authors declare no conflict of interest.

References

  • 1.Olvera Lopez E, Ballard BD, Jan A. Cardiovascular disease. StatPearls. 2021. [PubMed] [Google Scholar]
  • 2.Adegbola P, Aderibigbe I, Hammed W, Omotayo T. Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review. Am J Cardiovasc Dis 2017; 7: 19-32. [PMC free article] [PubMed] [Google Scholar]
  • 3.Bafadam S, Mahmoudabady M, Niazmand S, Rezaee SA, Soukhtanloo M. Cardioprotective effects of Fenugreek (Trigonella foenum-graceum) seed extract in streptozotocin induced diabetic rats. J Cardiovasc Thor Res 2021; 13: 28-36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Shabab S, Gholamnezhad Z, Mahmoudabady M. Protective effects of medicinal plant against diabetes induced cardiac disorder: a review. J Ethnopharmacol 2021; 265: 113328. [DOI] [PubMed] [Google Scholar]
  • 5.Abdi T, Mahmoudabady M, Marzouni HZ, Niazmand S, Khazaei M. Ginger (Zingiber Officinale Roscoe) extract protects the heart against inflammation and fibrosis in diabetic rats. Canadian J Diabetes 2021; 45: 220-7. [DOI] [PubMed] [Google Scholar]
  • 6.Jalali R, Mahmoodi M, Moosavian SP, Ferns GA, Sohrabi Z. Cinnamon supplementation improves blood pressure in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Clin Diabetol 2020; 9: 259-66. [Google Scholar]
  • 7.Rao PV, Gan SH. Cinnamon: A multifaceted medicinal plant. Evid Based Complementary Altern Med 2014; 2014: 642942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Mehrpouri M, Hamidpour R, Hamidpour M. [Cinnamon inhibits platelet function and improves cardiovascular system (Persian)]. J Med Plants 2020; 19: 1-11. [Google Scholar]
  • 9.Mollazadeh H, Hosseinzadeh H. Cinnamon effects on metabolic syndrome: a review based on its mechanisms. Iran J Basic Med Sci 2016; 19: 1258-70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Muhammad DRA, Dewettinck K. Cinnamon and its derivatives as potential ingredient in functional food – a review. Int J Food Properties 2017; 20 (Suppl 2): 2237-63. [Google Scholar]
  • 11.Gruenwald J, Freder J, Armbruester N. Cinnamon and health. Crit Rev Food Sci Nutr 2010; 50: 822-34. [DOI] [PubMed] [Google Scholar]
  • 12.Mahmoodnia L, Aghadavod E, Rafieian-Kopaei M. Ameliorative impact of cinnamon against high blood pressure; an updated review. J Renal Injury Prev 2017; 6: 171-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Vallverdu-Queralt A, Regueiro J, Martinez-Huelamo M, Alvarenga JFR, Leal LN, Lamuela-Raventos RM. A comprehensive study on the phenolic profile of widely used culinary herbs and spices: Rosemary, thyme, oregano, cinnamon, cumin and bay. Food Chem 2014; 154: 299-307. [DOI] [PubMed] [Google Scholar]
  • 14.Azimi P, Ghiasvand R, Feizi A, Hariri M, Abbasi B. Effects of cinnamon, cardamom, saffron, and ginger consumption on markers of glycemic control, lipid profile, oxidative stress, and inflammation in type 2 diabetes patients. Rev Diab Studies 2014; 11: 258-66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Akhavan Amjadi M, Mojab F, Shahbazzadegan S. [The study of Cinnamon effect on the primary dysmenorrheal and their symptom (Persian)]. J Ardabil Univ Med Sci 2009; 9: 204-9. [Google Scholar]
  • 16.Cha J, Kim CT, Kim TE, Cho YJ. Optimization of subcritical extraction process for cinnamon (Cinnamomum Cassia Blume) using response surface methodology. Food Sci Biotechnol 2019; 28: 1703-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Conde-Hernandez LA, Espinosa-Victoria JR, Trejo A, Guerrero-Beltran JA. CO2-supercritical extraction, hydrodistillation and steam distillation of essential oil of rosemary (Rosmarinus officinalis). J Food Eng 2017; 200: 81-6. [Google Scholar]
  • 18.Kallel I, Hadrich B, Gargouri B, et al. Optimization of cinnamon (Cinnamomum zeylanicum Blume) essential oil extraction: evaluation of antioxidant and antiproliferative effects. Evid Based Complem Altern Med 2019; 2019: 6498347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Baseri H, Haghighi-Asl A, Lotfollahi MN. Effects of operating parameters on the cinnamaldehyde content of extracted essential oil using various methods. Chem Engin Technol 2010; 33: 267-74. [Google Scholar]
  • 20.Gonçalves S, Romano A. Green approaches for the extraction of bioactives from natural sources for pharmaceutical applications. In: Inamuddin, Asiri AM, Kanchi S (eds.). Green Sustainable Process for Chemical and Environmental Engineering and Science. Elsevier; 2020; 249-67. [Google Scholar]
  • 21.Lee HG, Jo Y, Ameer K, Kwon JH. Optimization of green extraction methods for cinnamic acid and cinnamaldehyde from Cinnamon (Cinnamomum cassia) by response surface methodology. Food Sci Biotechnol 2018; 27: 1607-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Farazande M, Shabab S, Mahmoudabady M, Gholamnezhad Z. Effects of cinnamon on risk factors of cardiovascular diseases: a review paper. J Intern Med Today 2021; 28: 16-37. [Google Scholar]
  • 23.Nyadjeu P, Nguelefack-Mbuyo EP, Atsamo AD, Nguelefack TB, Dongmo AB, Kamanyi A. Acute and chronic antihypertensive effects of Cinnamomum zeylanicum stem bark methanol extract in L-NAME-induced hypertensive rats. BMC Complement Altern Med 2013; 13: 27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Akilen R, Pimlott Z, Tsiami A, Robinson N. Effect of shortterm administration of cinnamon on blood pressure in patients with prediabetes and type 2 diabetes. Nutrition 2013; 29: 1192-6. [DOI] [PubMed] [Google Scholar]
  • 25.Das G, Gonçalves S, Basilio Heredia J, et al. Cardiovascular protective effect of cinnamon and its major bioactive constituents: an update. J Funct Foods 2022; 97: 105045. [Google Scholar]
  • 26.Leach MJ, Kumar S. Cinnamon for diabetes mellitus. Cochrane Database Syst Rev 2012; 2012: CD007170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mousavi SM, Karimi E, Hajishafiee M, Milajerdi A, Amini MR, Esmaillzadeh A. Anti-hypertensive effects of cinnamon supplementation in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 2020; 60: 3144-54. [DOI] [PubMed] [Google Scholar]
  • 28.Zuo J, Zhao D, Yu N, et al. Cinnamaldehyde ameliorates diet-induced obesity in mice by inducing browning of white adipose tissue. Cell Physiol Biochem 2017; 1514-25. [DOI] [PubMed] [Google Scholar]
  • 29.Husain I, Ahmad R, Chandra A, Raza ST, Shukla Y, Mahdi F. Phytochemical characterization and biological activity evaluation of ethanolic extract of Cinnamomum zeylanicum. J Ethnopharmacol 2018; 219: 110-6. [DOI] [PubMed] [Google Scholar]
  • 30.Moraes FSA, Filho DGD, Caliari AI, et al. Chronic treatment with cinnamaldehyde prevents spontaneous atherosclerotic plaque development in ovariectomized LD Lr-/-female mice. Pharma Nutrition 2020; 13: 100205. [Google Scholar]
  • 31.Badalzadeh R, Shaghaghi M, Mohammadi M, Dehghan G, Mohammadi Z. The effect of cinnamon extract and long-term aerobic training on heart function, biochemical alterations and lipid profile following exhaustive exercise in male rats. Adv Pharm Bull 2014; 4 (Suppl 2): 515-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Li W, Zhi W, Zhao J, Yao Q, Liu F, Niu X. Cinnamaldehyde protects VSMCs against ox-LDL-induced proliferation and migration through S arrest and inhibition of p38, JNK/MAPKs and NF-κB. Vasc Pharmacol 2018; 108: 57-66. [DOI] [PubMed] [Google Scholar]
  • 33.WHO W. H. S . (2017). Monitoring Health for the SDGs, Sustainable Development Goals, Indic. 2.3 Mortal. Rate Attrib. To Cardiovasc. Dis. Cancer, diabetes or Chronic Respir. Dis, www.who.int/mediacentre/factsheets/fs375. In (pp. 31): WHO, World Health Statistics. [Google Scholar]
  • 34.Li W, Zhi W, Zhao J, et al. Cinnamaldehyde attenuates atherosclerosis via targeting the IκB/NF-κB signaling pathway in high fat diet-induced ApoE−/− mice. Food Function 2019; 10: 4001-9. [DOI] [PubMed] [Google Scholar]
  • 35.Kim NY, Trinh NT, Ahn SG, Kim SA. Cinnamaldehyde protects against oxidative stress and inhibits the TNF-α-induced inflammatory response in human umbilical vein endothelial cells. Int J Mol Med 2020; 46: 449-57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Nour OA, Shehatou GS, Rahim MA, El-Awady MS, Suddek GM. Cinnamaldehyde exerts vasculoprotective effects in hypercholestrolemic rabbits. Naunyn Schmiedebergs Arch Pharmacol 2018; 391: 1203-19. [DOI] [PubMed] [Google Scholar]
  • 37.Wang D, Hou J, Yang Y, et al. Cinnamaldehyde ameliorates high-glucose-induced oxidative stress and cardiomyocyte injury through transient receptor potential ankyrin 1. J Cardiovasc Pharmacol 2019; 74: 30-7. [DOI] [PubMed] [Google Scholar]
  • 38.Alvarez-Collazo J, Alonso-Carbajo L, López-Medina AI, et al. Cinnamaldehyde inhibits L-type calcium channels in mouse ventricular cardiomyocytes and vascular smooth muscle cells. Pflügers Archiv 2014; 466: 2089-99. [DOI] [PubMed] [Google Scholar]
  • 39.Huang J, Wang S, Luo X, Xie Y, Shi X. Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents. Thromb Res 2007; 119: 337-42. [DOI] [PubMed] [Google Scholar]
  • 40.Yang L, Wu QQ, Liu Y, Hu ZF, Bian ZY, Tang Q. Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy. Int J Clin Exp Pathol 2015; 8: 14345-54. [PMC free article] [PubMed] [Google Scholar]
  • 41.Anderson RA, Zhan Z, Luo R, et al. Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose. J Trad Complem Med 2016; 6: 332-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Pender DN, Crawford PF, Clark JM, Crawford AJ, Prats AA, Shah SA. Effect of water-soluble cinnamon extract on electrocardiographic parameters: an analysis of the CiNNaMON trial. Complement Ther Med 2018; 41: 302-5. [DOI] [PubMed] [Google Scholar]
  • 43.Hashemian M, Poustchi H, Murphy G, et al. Turmeric, pepper, cinnamon, and saffron consumption and mortality. J Am Heart Assoc 2019; 8: e012240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ashoor LA, Qusti SY. Potential interactions between Cinnamon and Metformin treatment in diabetic rats. Biosci Biotechnol Res Asia 2016; 7: 607-16. [Google Scholar]
  • 45.El-Beeh ME, Fouda YA, El-badry DA, El-Sayyad HI. Antiapoptic activity of cinnamon on some organs of 18 days rat fetuses of diabetic mother. Biosci Biotechnol Res Asia 2019; 16: 637-48. [Google Scholar]
  • 46.Fayaz E, Damirchi A, Zebardast N, Babaei P. Cinnamon extract combined with high-intensity endurance training alleviates metabolic syndrome via non-canonical WNT signaling. Nutrition 2019; 65: 173-8. [DOI] [PubMed] [Google Scholar]
  • 47.Mhammad HA, Jubrail AMS, Najeeb MK. Impact of cinnamon extract on hyperlipidemic and diabetic rats. Int J Chem Biomol Sci 2015; 1: 96-106. [Google Scholar]
  • 48.Rosado J. A study to determine the effects of cinnamon on blood glucose and lipid levels in people with type 2 diabetes [PhD. Dissertation]. University of Hawaii at Manoa, United States: 2010. [Google Scholar]
  • 49.Nostro A, Germano M, D’angelo V, Marino A, Cannatelli M. Extraction methods and bioautography for evaluation of medicinal plant antimicrobial activity. Lett Appl Microbiol 2000; 30: 379-84. [DOI] [PubMed] [Google Scholar]
  • 50.Brodowska KM, Brodowska AJ, Śmigielski K, Łodyga-Chruścińska E. Antioxidant profile of essential oils and extracts of cinnamon bark (Cinnamomum cassia). Eur J Biol Res 2016; 6: 310-6. [Google Scholar]
  • 51.Wang P, Yang Y, Wang D, et al. Cinnamaldehyde ameliorates vascular dysfunction in diabetic mice by activating Nrf2. Am J Hypertens 2020; 33: 610-9. [DOI] [PubMed] [Google Scholar]
  • 52.Maierean SM, Serban MC, Sahebkar A, et al. The effects of cinnamon supplementation on blood lipid concentrations: a systematic review and meta-analysis. J Clin Lipidol 2017; 11: 1393-406. [DOI] [PubMed] [Google Scholar]
  • 53.Sengsuk C, Sanguanwong S, Tangvarasittichai O, Tangvarasittichai S. Effect of cinnamon supplementation on glucose, lipids levels, glomerular filtration rate, and blood pressure of subjects with type 2 diabetes mellitus. Diabetol Int 2016; 7: 124-32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Haghighian HK, Farsad-Naeimi A, Gargari BP, Effect of cinnamon supplementation on blood glucose and lipid levels in type2 diabetic patients. J Paramed Sci 2011; 2(1): 1-6. [Google Scholar]
  • 55.Tarkhan MM, Balamsh KS, El-Bassossy HM. Cinnamaldehyde protects from methylglyoxal-induced vascular damage: effect on nitric oxide and advanced glycation end products. J Food Biochem 2019; 43: e12907. [DOI] [PubMed] [Google Scholar]
  • 56.Kang LL, Zhang DM, Ma CH, et al. Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation. Sci Rep 2016; 6: 27460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Song F, Li H, Sun J, Wang S. Protective effects of cinnamic acid and cinnamic aldehyde on isoproterenol-induced acute myocardial ischemia in rats. J Ethnopharmacol 2013; 150: 125-30. [DOI] [PubMed] [Google Scholar]
  • 58.Hadi A, Campbell MS, Hassani B, Pourmasoumi M, Salehi-sahlabadi A, Hosseini SA. The effect of cinnamon supplementation on blood pressure in adults: a systematic review and meta-analysis of randomized controlled trials. Clin Nutrition ESPEN 2020; 36: 10-6. [DOI] [PubMed] [Google Scholar]
  • 59.Jamali N, Jalali M, Saffari-Chaleshtori J, Samare-Najaf M, Samareh A. Effect of cinnamon supplementation on blood pressure and anthropometric parameters in patients with type 2 diabetes: a systematic review and meta-analysis of clinical trials. Diabetes Metab Syndr Clin Res Rev 2020; 14: 119-25. [DOI] [PubMed] [Google Scholar]
  • 60.Shirzad F, Morovatdar N, Rezaee R, Tsarouhas K, Abdollahi Moghaddam A. Cinnamon effects on blood pressure and metabolic profile: a double-blind, randomized, placebo-controlled trial in patients with stage 1 hypertension. Avicenna J Phytomed 2021; 11: 91-100. [PMC free article] [PubMed] [Google Scholar]
  • 61.Zamani T, Shahmerzadi FE, Zarrin R. The effect of oral supplementation of cinnamon on weight loss and blood pressure in patients with type 2 diabetes: a randomized clinical trial. J Nutr Sci Dietet 2017; 3: 1-6. [Google Scholar]
  • 62.Medagama AB. The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials. Nutrition J 2015; 14: 108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Santos HO, da Silva GA. To what extent does cinnamon administration improve the glycemic and lipid profiles? Clin Nutr ESPEN 2018; 27: 1-9. [DOI] [PubMed] [Google Scholar]
  • 64.Deyno S, Eneyew K, Seyfe S, et al. Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: a meta-analysis and meta-regression. Diabetes Res Clin Pract 2019: 156: 107815. [DOI] [PubMed] [Google Scholar]
  • 65.Mnafgui K, Derbali A, Sayadi S, Gharsallah N, Elfeki A, Allouche N. Anti-obesity and cardioprotective effects of cinnamic acid in high fat diet-induced obese rats. J Food Sci Technol 2015; 52: 4369-77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Yazdanpanah Z, Azadi-Yazdi M, Hooshmandi H, Ramezani-Jolfaie N, SalehiAbargouei A. Effects of cinnamon supplementation on body weight and composition in adults: a systematic review and meta-analysis of controlled clinical trials. Phytoter Res 2020; 34: 448-63. [DOI] [PubMed] [Google Scholar]
  • 67.Vafa MR, et al. Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetes patients. Int J Prev Med 2012; 3: 531-6. [PMC free article] [PubMed] [Google Scholar]
  • 68.Bernardo MA, Silva ML, Santos E, et al. Effect of cinnamon tea on postprandial glucose concentration. J Diabetes Res 2015; 2015: 913651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Pulungan A, Pane YS. The benefit of cinnamon (Cinnamomum burmannii) in lowering total cholesterol levels after consumption of high-fat containing foods in white mice (Mus musculus) models. F1000Res 2020; 9.: 168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Shishehbor F, Rezaeyan Safar M, Rajaei E, Haghighizadeh MH. Cinnamon consumption improves clinical symptoms and inflammatory markers in women with rheumatoid arthritis. J Am Coll Nutr 2018; 37: 685-90. [DOI] [PubMed] [Google Scholar]
  • 71.Pishdad S, Nadjarzadeh A, Abargouei AS, Nazari EK, Papoli M. Effect of cumin and cinnamon on lipid profile in middle-aged women with dyslipidemia: a double blind, randomized controlled clinical trial. Progress Nutr 2018; 20: 232-7. [Google Scholar]
  • 72.Ranasinghe P, Jayawardena R, Pigera S, et al. Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial. BMC Complementary Altern Med 2017; 17: 550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Borzoei A, Rafraf M, Niromanesh S, Farzadi L, Narimani F, Doostan F. Effects of cinnamon supplementation on antioxidant status and serum lipids in women with polycystic ovary syndrome. J Trad Complem Med 2018; 8: 128-33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Davari M, Hashemi R, Mirmiran P, et al. Effects of cinnamon supplementation on expression of systemic inflammation factors, NF-kB and Sirtuin-1 (SIRT1) in type 2 diabetes: a randomized, double blind, and controlled clinical trial. Nutrition J 2020; 19: 1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Medical Sciences. Atherosclerotic Diseases are provided here courtesy of Termedia Publishing

RESOURCES